Urticaria is characterized by sudden appearance of wheals and/or angioedema.
The intensity of the pruritus varies but may be severe enough to disrupt sleep, work or school.
It is classified acute if the urticaria has been present for <6 weeks and chronic if >6 weeks. A specific cause is more likely to be identified in acute cases.
It can be triggered by immunological or nonimmunological mechanism.

Urticaria Diagnosis


  • Diagnosis is based on patient’s history and physical examination


  • Urticaria is classified as acute or chronic, and as spontaneous (no triggering factor) or inducible (a particular triggering factor is identified)
    • A specific cause is more likely to be identified in acute cases
  •  Can be triggered by immunological or non-immunological mechanism

Acute Urticaria

  • Lesions occurring ≤6 weeks in duration and usually without angioedema
  • More common in children and young adults and tends to have a triggering event
  • Routine laboratory work-ups are not required, except when the cause of the urticaria points to a type I food hypersensitivity or other triggering factors like medications [eg non-steroidal anti-inflammatory drugs (NSAIDs)]

Chronic Urticaria

  • More common in adults (3rd and 4th decades of life), symptoms last >6 weeks

Chronic Spontaneous Urticaria

  • Presence of wheals, angioedema or both for >6 weeks due to factors that are identifiable or idiopathic

Inducible Urticaria

  • Cold urticaria
  • Delayed pressure urticaria
  • Heat urticaria
  • Symptomatic dermographism
    • Daily lesions and recurrent episodic lesions are not differentiated
  • Solar urticaria
  • Vibratory angioedema
  • Aquagenic urticaria
  • Cholinergic urticaria
  • Contact urticaria

Autoimmune Chronic Spontaneous Urticaria (ACU)

  • Proposed gold standard for diagnosis of ACU (combination of all 3 parameters):
    • Positive bioassay [eg basophil histamine release assay (BHRA), basophil activation marker expression] AND
    • Positive autoreactivity [eg positive autologous serum skin test (ASST)] AND
    • Positive immunoassay for specific IgG autoantibodies against FcεRIα and/or anti-IgE

Physical Examination

Look for typical lesions of urticaria

  • Wheals which typically are fleeting, lasting within 30 minutes-24 hours, have a central swelling of variable size surrounded by erythema and associated with itching, sometimes burning sensation
  • Angioedema characterized by a sudden evident swelling of the lower dermis and subcutis or mucous membranes, that is sometimes painful which may last up to 72 hours
  • Lesions may appear on any part of the body

Stroke the arm to test for dermographism/dermatographism

  • Discontinue antihistamine therapy for at least 2-3 days, immunosuppressive therapy for at least a week

Chronic Urticaria

  • Diagnostic examinations are based on the patient’s history and physical examination

Chronic Spontaneous Urticaria

  • Consider other possible diagnoses in patients with presentations indicative of chronic urticaria
  • Further tests are requested if indicated by the patient’s history and physical examination, most notably in patients with chronic and/or on-and-off disease presentation
  • Assess disease activity of chronic spontaneous urticaria
    • Several guidelines recommend using the Urticaria Activity Score (UAS7) system in assessing disease severity and treatment effectivity
    • Summation of scores of symptoms during a 7-day period
      • 0 = no wheals, no pruritus
      • 1 = mild wheals (<20 wheals within 24 hours) + mild (nontroublesome) pruritus 
      • 2 = moderate wheals (20-50 wheals within 24 hours) + moderate (troublesome but does not interfere with daily activities or sleep) pruritus 
      • 3 = intense wheals (>50 wheals within 24 hours or large confluent wheals) + intense (severely troublesome, interferes with daily activities and sleep) pruritus

Chronic Inducible Urticaria

  • Provocation threshold measurements are used to assess disease activity, while the urticaria control test (UCT) is used to determine how well the disease is prevented from recurring
Subtype Test Extended Diagnostic Tests1
(Based on the patient's history)
Spontaneous Urticaria
Acute spontaneous urticaria None None2
Chronic spontaneous urticaria Differential blood count, erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP) Perform tests for: Infectious illnesses, functional autoantibodies [eg autologous serum skin test (ASST)], allergy, thyroid abnormalities, presence of chronic inducible urticaria, severe systemic illnesses, others (skin biopsy)
Inducible Urticaria
Cold urticaria Cold provocation and threshold test (eg ice cubes, cold water) Differential blood count and ESR or CRP, rule out other diseases/infections
Delayed pressure Pressure test (0.2-1.5 kg/cm2 for 10 and 20 minutes) and threshold test None
Heat urticaria Heat provocation and threshold test (eg warm water) None
Solar Ultraviolet (UV) and visible light of different wavelengths and threshold test Rule out other light-induced dermatoses
Symptomatic dermographism Test by stroking the arm and threshold test Differential blood count, ESR or CRP 
Vibratory angioedema Test using vibration (eg mixer, Vortex) None
Aquagenic Provocation test/apply wet cloths set at body temperature for 20 minutes None
Cholinergic Exercise and hot bath provocation, threshold test None
Contact Cutaneous provocation test, prick/patch test (see results after 20 minutes) None
Exercise-induced History of urticaria after exercise, appearing with or without food intake but not after a hot bath None
Modified from: The European Academy of Allergology and Clinical Immunology (EAACI)/Global Asthma and Allergy European Network (GA2LEN)/European Dermatology Forum (EDF)/World Allergy Organization (WAO) guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018; EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy. 2006.
1Depends on the cause being considered
2Except when the patient’s history indicates the need for testing
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, Yesterday
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
6 days ago
Daily intake of cow’s milk formula in early life helps prevent the development of cow’s milk allergy later on without competing with breastfeeding, a recent study has found.